Offerings - Offering: 1 |
May 26, 2026
USD ($)
shares
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Ordinary shares, par value Euro0.50 per share |
| Amount Registered | shares | 147,369,381 |
| Maximum Aggregate Offering Price | $ 6,486,145,894.68 |
| Fee Rate | 0.01381% |
| Amount of Registration Fee | $ 895,736.75 |
| Rule 457(f) | true |
| Amount of Securities Received | shares | 225,369,906 |
| Value of Securities Received, Per Share | 28.78 |
| Value of Securities Received | $ 6,486,145,894.68 |
| Fee Note MAOP | $ 6,486,145,894.68 |
| Offering Note | (1) Represents the maximum number of Akzo Nobel N.V. ("AkzoNobel") ordinary shares estimated to be issuable upon the completion of the transactions contemplated by the Merger Agreement, dated as of November 18, 2025 by and between AkzoNobel and Axalta Coating Systems Ltd. ("Axalta") (the "merger agreement") described in AkzoNobel's registration statement on Form F-4 (the "Registration Statement") with which this exhibit is filed, calculated as the product obtained by multiplying (i) the exchange ratio of 0.6539 by (ii) 225,369,906, which is the sum of (A) 214,018,930, the number of Axalta common shares outstanding as of May 21, 2026, and (B) 11,350,976, the maximum number of Axalta common shares authorized for issuance pursuant to Axalta's existing equity plans or otherwise permitted to be issued pursuant to the terms of the merger agreement described in the Registration Statement. (2) Estimated solely for purposes of calculating the amount of the registration fee, the proposed maximum aggregate offering price of the securities being registered was calculated pursuant to Rules 457(c) and 457(f)(1) as the product obtained by multiplying (i) $28.78, the average of the high and low prices per share of Axalta common shares as reported on the New York Stock Exchange on May 21, 2026, by (ii) 225,369,906 (which represents the estimated maximum number of Axalta common shares that may be exchanged in the transactions contemplated by the merger agreement, as described in footnote (1) above). |